Fusion Antibodies is a contract research organisation based in Belfast, Northern Ireland. It works with biopharmaceutical and diagnostic companies, offering antibody discovery, engineering and humanisation services. Its scientists help clients develop antibody-based medicines and tests, from early discovery through to candidate selection. The company provides these laboratory and development services to customers in the pharmaceutical and biotechnology sectors, supporting their own research programmes rather than selling its own branded medicines.
On this site Fusion Antibodies PLC appears as a stock on the London Stock Exchange (UK), code FAB, with prices in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3490 of 3788 on the London Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
6/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-54.6%
From 52-week high-71.4%
MomentumWeak
10/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-48.8%
6-month return-59.3%
12-month, skipping last month-14.5%
Stability (higher is calmer)Weak
8/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)82.1%
Worst drawdown, 1 year (smaller is calmer)-71.4%
LiquidityFair
68/100
Moderate trading activity.
See the numbers →
Avg daily value traded4.80M GBX
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 4.700 – 20.000Daily closes, split-adjusted
Signals
50-day average10.098
200-day average12.111
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.001
Technical summary
Daily
Strongly bearish
3 bullish · 1 neutral · 12 bearish
Weekly
Strongly bearish
1 bullish · 0 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
6.23
Bearish
EMA 10
6.45
Bearish
SMA 20
8.38
Bearish
EMA 20
7.75
Bearish
SMA 50
10.10
Bearish
EMA 50
9.40
Bearish
SMA 100
10.61
Bearish
EMA 100
10.46
Bearish
SMA 200
12.11
Bearish
EMA 200
11.29
Bearish
Oscillators (daily)
RSI (14)
20.21
Bullish
MACD (12, 26)
-1.51
Bearish
Momentum (12)
-45.00
Bearish
Stochastic %K (14)
13.79
Bullish
Williams %R (14)
-86.21
Bullish
CCI (20)
-84.48
Neutral
Pivot points (classic, last session)
S3
4.50
S2
4.87
S1
5.19
Pivot
5.56
R1
5.88
R2
6.25
R3
6.57
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in GBX. Educational only, not financial advice.
